A detailed history of Wisconsin Capital Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wisconsin Capital Management LLC holds 7,121 shares of VRTX stock, worth $2.92 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
7,121
Previous 2,512 183.48%
Holding current value
$2.92 Million
Previous $1.18 Million 181.31%
% of portfolio
1.76%
Previous 0.61%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$460.0 - $505.78 $2.12 Million - $2.33 Million
4,609 Added 183.48%
7,121 $3.31 Million
Q2 2024

Aug 01, 2024

BUY
$392.81 - $485.53 $986,738 - $1.22 Million
2,512 New
2,512 $1.18 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Wisconsin Capital Management LLC Portfolio

Follow Wisconsin Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wisconsin Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wisconsin Capital Management LLC with notifications on news.